BAYRY
Bayer AG (ADR)

2,783
Mkt Cap
$49.83B
Volume
475,976.00
52W High
$13.00
52W Low
$5.30
PE Ratio
-146.08
BAYRY Fundamentals
Price
$12.90
Prev Close
$12.68
Open
$12.80
50D MA
$10.04
Beta
0.43
Avg. Volume
512,862.32
EPS (Annual)
-$0.7025
P/B
1.43
Rev/Employee
$543,158.75
Loading...
Loading...
News
all
press releases
Top Analyst Reports for Agnico Eagle, Monster & General Motors
Analyst reports spotlight Agnico Eagle Mines as it executes growth projects, benefits from higher gold prices, and strengthens its position after major deals.
Zacks·19h ago
News Placeholder
More News
News Placeholder
J&J Stock Down Despite Q4 Earnings Beat, Oncology Drugs Drive Sales
JNJ beat Q4 earnings and sales estimates as strong oncology drug growth, led by Darzalex, offset biosimilar pressure on Stelara.
Zacks·1d ago
News Placeholder
Is Arcellx (ACLX) Stock Outpacing Its Medical Peers This Year?
Here is how Arcellx, Inc. (ACLX) and Bayer Aktiengesellschaft (BAYRY) have performed compared to their sector so far this year.
Zacks·1d ago
News Placeholder
Best Value Stocks to Buy for January 21st
BNPQY, BAYRY and DLAKY made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 21, 2026.
Zacks·1d ago
News Placeholder
New Strong Buy Stocks for January 21st
BAYRY, DAKT, ZTO, LRLCY and AVAH have been added to the Zacks Rank #1 (Strong Buy) List on January 21, 2026.
Zacks·1d ago
News Placeholder
Bayer Shares Jump as Supreme Court Agrees to Review Key Roundup Case
BAYRY jumps 6.4% after the Supreme Court agrees to review the Durnell Roundup case, a key test of federal preemption in glyphosate litigation.
Zacks·2d ago
News Placeholder
Bayer Stock Jumps on Nubeqa Outlook, Presents Pharma Strategy
BAYRY jumps 6.6% after partner Orion said Nubeqa sales tied to Bayer could top ???1B long term. Bayer also announced pharma priorities at J.P. Morgan Healthcare Conference.
Zacks·7d ago
News Placeholder
Bayer Accelerates Growth With siRNA, AI Deals and Pipeline Progress
Bayer AG enters into collaborations to develop a heart-targeted siRNA therapy and AI technology, expanding its push into next-gen genetic medicines.
Zacks·13d ago
News Placeholder
Here's Why Bayer Aktiengesellschaft (BAYRY) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks·15d ago
News Placeholder
REGN Soars 41% in Six Months: Is There More Upside Potential in 2026?
Regeneron shares are up 41% in six months as FDA approvals, strong Dupixent profits and oncology gains lift investor confidence.
Zacks·20d ago
<
1
2
...
>

Latest BAYRY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.